Related Experiment Videos
Prospective observational study of isoflavone and the risk of stroke recurrence: potential clinical implications
Insights
Higher dietary isoflavone intake in stroke patients was linked to a reduced risk of recurrent stroke and major adverse cardiovascular events (MACE). This suggests isoflavones may offer secondary protection, warranting further investigation.
Area of Science:
- Cardiovascular Research
- Nutritional Science
- Stroke Medicine
Background:
- The effect of isoflavones on recurrent cardiovascular events remains unclear.
- Investigating dietary isoflavone intake's role in secondary stroke prevention is crucial.
Purpose of the Study:
- To examine the association between isoflavone consumption and the risk of stroke recurrence.
- To assess the relationship between isoflavone intake and major adverse cardiovascular events (MACE) in stroke survivors.
Main Methods:
- Prospective follow-up of 127 patients with a history of atherothrombotic/hemorrhagic stroke for 30 months.
- Assessment of stroke recurrence, MACE, brachial flow-mediated dilatation (FMD), and isoflavone intake via food frequency questionnaire.
Main Results:
- Higher isoflavone intake was independently associated with improved FMD (Pearson R=0.23, p=0.012).
- Patients with higher isoflavone intake demonstrated significantly longer recurrence-free survival (19.0 vs. 5.0 months, p=0.021) and MACE-free survival (19.0 vs. 4.0 months, p=0.013).
- Higher isoflavone intake predicted a significantly lower risk of stroke recurrence (HR 0.18, p=0.043) and MACE (HR 0.16, p=0.030).
Conclusions:
- Increased isoflavone intake in stroke patients correlates with prolonged recurrence-free survival and reduced risk of stroke recurrence and MACE.
- These protective effects appear independent of baseline vascular function.
- Randomized controlled trials are needed to confirm if isoflavones provide clinically significant secondary protection in stroke patients.
Background:
Whether isoflavone has any effect on recurrent cardiovascular events is unknown.
Objective:
To investigate the relations between isoflavone intake and the risk of stroke recurrence.
Subjects And Methods:
We recruited 127 consecutive patients with prior history of atherothrombotic/ hemorrhagic stroke (mean age: 67 ± 11 years, 69% male) and prospectively followed up for a mean duration of 30 months. Stroke recurrence and major adverse cardiovascular events (MACE) were documented. Brachial flow-mediated dilatation (FMD) was measured using high-resolution ultrasound. Isoflavone intake was estimated using a validated food frequency questionnaire.
Results:
Median isoflavone intake was 6.9 (range: 2.1 - 14.5) mg/day. Isoflavone intake was independently associated with increased FMD (Pearson R=0.23, p=0.012). At 30 months, there were 10 stroke recurrence and 12 MACE. Kaplan-Meier analysis showed that patients with isoflavone intake higher than median value had significantly longer median stroke recurrence-free survival time (19.0 [range: 10.4 - 27.6] mth versus 5.0 [range: 4.1 - 5.9] mth, p=0.021) and MACE-free survival time (19.0 [range: 10.4 - 27.6] mth versus 4.0 [range: 2.4 - 5.6] mth, p=0.013). Using multivariate cox regression, higher isoflavone intake was an independent predictor for lower risk of stroke recurrence (hazards ratio 0.18 [95%CI: 0.03 - 0.95], risk reduction 82%, p=0.043) and MACE (hazards ratio 0.16 [95%CI: 0.03 - 0.84], risk reduction 84%, p=0.030).
Conclusions:
Higher isoflavone intake in stroke patients was associated with prolonged recurrence-free survival, and reduced risk of stroke recurrence and MACE independent of baseline vascular function. Whether isoflavone may confer clinically significant secondary protection in stroke patients should be further investigated in a randomized controlled trial.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Coronary Artery Disease IV: Preventive Measures
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...